Kyriakos E. Kypreos

3.0k total citations
89 papers, 2.4k citations indexed

About

Kyriakos E. Kypreos is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Kyriakos E. Kypreos has authored 89 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 40 papers in Endocrinology, Diabetes and Metabolism and 32 papers in Surgery. Recurrent topics in Kyriakos E. Kypreos's work include Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Lipid metabolism and disorders (21 papers) and Peroxisome Proliferator-Activated Receptors (20 papers). Kyriakos E. Kypreos is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Lipid metabolism and disorders (21 papers) and Peroxisome Proliferator-Activated Receptors (20 papers). Kyriakos E. Kypreos collaborates with scholars based in Greece, United States and Cyprus. Kyriakos E. Kypreos's co-authors include Vassilis I. Zannis, Eleni A. Karavia, Evangelia Zvintzou, Dionysios J. Papachristou, Abdulmaged M. Traish, Eva Xepapadaki, Περιστέρα-Ιωάννα Πετροπούλου, Ko Willems van Dijk, Louis M. Havekes and Angeliki Chroni and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Biochemistry.

In The Last Decade

Kyriakos E. Kypreos

88 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyriakos E. Kypreos Greece 33 850 780 759 440 426 89 2.4k
Josep Julve Spain 27 784 0.9× 743 1.0× 1.0k 1.4× 372 0.8× 414 1.0× 133 2.4k
Daisaku Masuda Japan 29 694 0.8× 684 0.9× 931 1.2× 493 1.1× 645 1.5× 96 2.5k
Saša Frank Austria 34 611 0.7× 1.1k 1.4× 1.0k 1.3× 373 0.8× 592 1.4× 98 3.1k
Yusaku Mori Japan 24 723 0.9× 1.1k 1.4× 515 0.7× 514 1.2× 313 0.7× 81 2.3k
Chu‐Huang Chen Taiwan 32 371 0.4× 1.3k 1.6× 861 1.1× 441 1.0× 491 1.2× 111 3.4k
Kazuhisa Tsukamoto Japan 30 723 0.9× 1.6k 2.1× 960 1.3× 911 2.1× 313 0.7× 103 3.5k
Aino Soro‐Paavonen Finland 23 1.0k 1.2× 602 0.8× 450 0.6× 612 1.4× 597 1.4× 30 2.5k
Jörg Kotzka Germany 32 492 0.6× 1.4k 1.8× 663 0.9× 629 1.4× 301 0.7× 97 2.6k
Alexandra А. Melnichenko Russia 25 366 0.4× 1.1k 1.4× 623 0.8× 450 1.0× 445 1.0× 74 2.8k
Masahiko Igarashi Japan 23 682 0.8× 1.2k 1.5× 462 0.6× 683 1.6× 596 1.4× 56 3.2k

Countries citing papers authored by Kyriakos E. Kypreos

Since Specialization
Citations

This map shows the geographic impact of Kyriakos E. Kypreos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyriakos E. Kypreos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyriakos E. Kypreos more than expected).

Fields of papers citing papers by Kyriakos E. Kypreos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyriakos E. Kypreos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyriakos E. Kypreos. The network helps show where Kyriakos E. Kypreos may publish in the future.

Co-authorship network of co-authors of Kyriakos E. Kypreos

This figure shows the co-authorship network connecting the top 25 collaborators of Kyriakos E. Kypreos. A scholar is included among the top collaborators of Kyriakos E. Kypreos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyriakos E. Kypreos. Kyriakos E. Kypreos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Xepapadaki, Eva, et al.. (2021). HDL and type 2 diabetes: the chicken or the egg?. Diabetologia. 64(9). 1917–1926. 48 indexed citations
4.
Akoumianakis, Ioannis, Evangelia Zvintzou, Kyriakos E. Kypreos, & Theodosios D. Filippatos. (2021). ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets. Current Atherosclerosis Reports. 23(5). 20–20. 47 indexed citations
5.
Zvintzou, Evangelia, et al.. (2019). Pleiotropic effects of apolipoprotein A-Ⅱ on high-density lipoprotein functionality, adipose tissue metabolic activity and plasma glucose homeostasis. Journal of Biomedical Research. 34(1). 14–14. 15 indexed citations
6.
Xepapadaki, Eva, Giuseppe Maulucci, Caterina Constantinou, et al.. (2019). Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1351–1360. 21 indexed citations
7.
Kodela, Elisavet, Sevasti Karaliota, Yassemi Koutmani, et al.. (2018). Strain-specific Differences in the Effects of Lymphocytes on the Development of Insulin Resistance and Obesity in Mice.. PubMed. 68(1). 15–24. 3 indexed citations
8.
Maulucci, Giuseppe, Ofir Cohen, Anna Sansone, et al.. (2016). Fatty acid-related modulations of membrane fluidity in cells: detection and implications. Free Radical Research. 50(sup1). S40–S50. 134 indexed citations
9.
Karavia, Eleni A., Christina Kalogeropoulou, Nikolaos Papachristou, et al.. (2015). Deficiency in apolipoprotein A-I ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition. European Journal of Pharmacology. 766. 76–85. 14 indexed citations
10.
Constantinou, Caterina, Περιστέρα-Ιωάννα Πετροπούλου, Evangelia Zvintzou, et al.. (2014). The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations. Journal of Lipid Research. 55(7). 1434–1447. 23 indexed citations
11.
Karavia, Eleni A., et al.. (2012). Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. Osteoarthritis and Cartilage. 21(2). 322–330. 74 indexed citations
12.
Rallidis, Lοukianos S., George Sakellaropoulos, Stefan Lehr, et al.. (2011). Qualitative characteristics of HDL in young patients of an acute myocardial infarction. Atherosclerosis. 220(1). 257–264. 31 indexed citations
13.
Dijk, Ko Willems van, Kyriakos E. Kypreos, Frits J. Fallaux, & Jurre Hageman. (2010). Adenovirus-Mediated Gene Transfer. Methods in molecular biology. 693. 321–343. 7 indexed citations
14.
Gerritsen, Gery, Caroline C. van der Hoogt, Frank G. Schaap, et al.. (2008). ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency. Journal of Lipid Research. 49(5). 1048–1055. 4 indexed citations
15.
Καραγιαννίδης, Ιορδάνης, et al.. (2008). Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS Journal. 275(19). 4796–4809. 65 indexed citations
16.
Zannis, Vassilis I., Γεώργιος Κούκος, Konstantinos Drosatos, et al.. (2008). Discrete roles of apoA‐I and apoE in the biogenesis of HDL species: Lessons learned from gene transfer studies in different mouse models. Annals of Medicine. 40(sup1). 14–28. 22 indexed citations
17.
Kypreos, Kyriakos E. & Vassilis I. Zannis. (2007). Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT. Biochemical Journal. 403(2). 359–367. 79 indexed citations
18.
19.
Gerritsen, Gery, Kyriakos E. Kypreos, André van der Zee, et al.. (2003). Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain. Journal of Lipid Research. 44(2). 408–414. 9 indexed citations
20.
Dijk, Ko Willems van, Kyriakos E. Kypreos, Christine d’Oliveira, & Frits J. Fallaux. (2003). Adenovirus-Mediated Gene Transfer. Humana Press eBooks. 209. 231–248. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josep Julve Breakdown of academic impact, for papers by Daisaku Masuda Breakdown of academic impact, for papers by Saša Frank Breakdown of academic impact, for papers by Yusaku Mori Breakdown of academic impact, for papers by Chu‐Huang Chen Breakdown of academic impact, for papers by Kazuhisa Tsukamoto Breakdown of academic impact, for papers by Aino Soro‐Paavonen Breakdown of academic impact, for papers by Jörg Kotzka Breakdown of academic impact, for papers by Alexandra А. Melnichenko Breakdown of academic impact, for papers by Masahiko Igarashi
Rankless by CCL
2026